Skip to main content

DarioHealth Corp.

For the period ended Mar 31, 2026. Filed May 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

DRIO$2.38-12.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Interim Balance Sheets (Unaudited)

U.S. dollars in thousands

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · ​ ​ ​ · 2026 · ​ ​ ​ · 2025
ASSETS​​​​​​
​​​​​​​
CURRENT ASSETS: · ​ · ​ · ​ · ​
Cash and cash equivalents​$14,977​$21,803
Short-term bank deposits​​5,035​​4,214
Short-term restricted bank deposits​252​229
Trade receivables, net​2,219​2,144
Inventories​4,172​4,316
Other accounts receivable and prepaid expenses​2,079​2,361
​​​​​​​
Total current assets​28,734​35,067
​​​​​​​
NON-CURRENT ASSETS:​​​​
Deposits​​80​​80
Operating lease right of use assets​607​717
Long-term assets​​454​​304
Property and equipment, net​​511​​549
Intangible assets, net​​15,468​​15,931
Goodwill​​57,427​​57,427
​​​​​​​
Total non-current assets​​74,547​​75,008
​​​​​​​
Total assets​$103,281​$110,075

CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS** (UNAUDITED)**

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · ​ ​ ​ · 2026 · ​ ​ ​ · 2025
LIABILITIES AND STOCKHOLDERS’ EQUITY · ​ · ​ · ​ · ​ · ​
​​​​​​​
CURRENT LIABILITIES: · ​ · ​ · ​ · ​
Trade payables​$3,468​$2,928
Deferred revenues​501​714
Operating lease liabilities​​378​​430
Other accounts payable and accrued expenses​5,010​5,251
​​​​​​​
Total current liabilities​9,357​9,323
​​​​​​​
NON-CURRENT LIABILITIES​​​​​​
Operating lease liabilities​507​571
Long-term loan​30,931​30,747
Warrant liability​​23​​1,466
Other long-term liabilities​83​46
​​​​​​​
Total non-current liabilities​​31,544​​32,830
​​​​​​​
STOCKHOLDERS’ EQUITY **​​​​
Common stock of $0.0001 par value - authorized: 400,000,000 shares; issued and outstanding: 7,299,026 and 6,905,948 shares on March 31, 2026 and December 31, 2025, respectively​4​4
Additional paid-in capital​522,703​519,996
Accumulated deficit​(460,327)​(452,078)
​​​​​​​
Total stockholders’ equity​62,380​67,922
​​​​​​​
Total liabilities and stockholders’ equity​$103,281​$110,075
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.